Why in hospital following transoral robotic lingual tonsillectomy?

Mikkel Hjordt Holm Larsen*, Hani Ibrahim Channir, Anne Kathrine Østergaard Madsen, Niclas Rubek, Padraig O'Leary, Thomas Kjærgaard, Henrik Kehlet, Christian von Buchwald

*Corresponding author af dette arbejde


BACKGROUND: The reported hospital length of stay (LOS) following transoral robotic surgery lingual tonsillectomy (TORS-L) is variable, with limited understanding of the factors requiring hospitalization and no evidence-based criteria for discharge.

AIMS/OBJECTIVES: This observational cohort study investigated factors hindering discharge following TORS-L in a well-defined postoperative care program.

METHODS: Patients were included between August 2020 and October 2022. A discharge scheme was filled out twice daily, specifying the factor(s) for hospitalization among patients undergoing TORS-L. This trial was a sub-investigation of a national multicentre randomized clinical trial (RCT) testing the efficiency of high-dose dexamethasone on postoperative pain control. Participation in the RCT demanded admission to the fourth postoperative day as dexamethasone/placebo was given intravenously in repeated dosages till day 4 postoperatively.

RESULTS: Eighteen patients were included in the analysis. The main factor for hospitalization was nutritional difficulties, while pain was a limiting factor for discharge only on the first postoperative 1-3 days. More than half of the patients could have potentially been discharged on postoperative day 2 when omitting the RCT treatment plan in the analysis.

CONCLUSION: The study estimates that the majority of patients may be discharged on postoperative day 2 following TORS-L.

TidsskriftActa Oto-Laryngologica
Udgave nummer9
Sider (fra-til)796-800
Antal sider5
StatusUdgivet - sep. 2023


Dyk ned i forskningsemnerne om 'Why in hospital following transoral robotic lingual tonsillectomy?'. Sammen danner de et unikt fingeraftryk.